Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    Europe Regenerative Medicine Market Forecast 2027 By Type (Cell Therapy, Tissue Engineering, Gene Therapy), By Application (Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound Healing, Ophthalmology), Research Report, Country Outlook (Germany, UK, France, Italy, Spain, Sweden, The Netherlands, Russia, Denmark, Switzerland, Poland, Belgium, Norway, Finland), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: October 2021   |   Report ID: GR1981   |   Delivery: PDF  Request Free Sample

    Europe Regenerative Medicine Market size crossed USD 9.5 billion in 2020 and is predicted to exhibit a CAGR of 18.9% between 2021 and 2027.

    Rising prevalence rate of several chronic diseases such as musculoskeletal, cardiovascular, cancer and numerous infectious conditions, will offer lucrative opportunities for the market growth. Furthermore, high adoption rate of approved regenerative medicine therapies used in treatment of several diseases to reduce disease-associated mortality rate will stimulate demand for regenerative medicine. Additionally, several new therapeutic applications of stem cell therapy and gene therapies to treat chronic ailments for better clinical outcomes will boost market demand.


    Europe Regenerative Medicine Market

    Get more details on this report - Request Free Sample PDF

    Continuous increase in clinical studies for better understanding of regenerative medicine in numerous treatments will offer unprecedented growth opportunities to the market. Moreover, increasing investment in discovery of novel medicine will result into development of potential therapies for range clinical applications. For instance, stem cells and platelet rich plasma are used to repair tissue and defected joints as well as enhance body’s own ability to heal injury. Also, these medicines are used to treat eyesight loss and heart repairing with advantage of faster recovery rate.

    COVID-19 pandemic has positively impacted the Europe regenerative medicine market. Several ongoing clinical studies need for innovative medicine for faster recovery of patients and introduction of new products will contribute to the regional market revenue. Furthermore, strong presence of market players in region have showcased significant market revenue growth during COVID-19 pandemic.

    Europe Market, By Type

    Cell therapy segment revenue in the Europe regenerative medicine market was over USD 5.5 billion in 2020, attributed to increasing advancements in stem cell therapy applications in multiple disease areas. For instance, the growing adoption of stem cell therapies in treatment of ischemic heart diseases and ophthalmology disorders. Additionally, shortage of organs for transplantation will stimulate segment growth in several European economies.

    Europe Market, By Application

    Oncology segment will likely showcase 20.6% growth rate in the Europe regenerative medicine market during the forecast timeline, owing to increasing incidence of cancer in the European countries. Extensive product pipeline for cancer treatment will enhance segment growth. Further, regenerative medicine used in cancer immunotherapy offers advantage to target and eliminate disease cells and will fuel the product demand.

    Europe Market, By Country

    France regenerative medicine market held around 10% revenue share in 2020. Increasing adoption of innovative therapies in treatment of chronic diseases will drive the industry expansion. Rising incidence of several chronic diseases in the country will further boost the product demand. Moreover, high investment in development of healthcare infrastructure and high spending capacity on healthcare will propel the market growth. Moreover, government fundings and reimbursement policies in facilities along with new product launches in the region will impel the market size.

    Competitive Industry Landscape

    Some of the notable players involved in the market include Novartis, GlaxoSmithKline, Smith and Nephew, Bristol Myers Squibb, Bluebird BIO, Kite, GC pharma, Biosolutions, Terumo BCS, Avita Medical, Orchard Therapeutics, Spark Therapeutics, and Amgen.

    These companies are undertaking several strategic initiatives such as product launch, acquisition & merger, and collaborations to expand their market footprint. For instance, in November 2020, Novartis announced collaboration with Mesoblast for development, manufacturing and commercialization of remestemcel-L in treatment of acute respiratory syndromes as well as ARDs associated with SARS COV2 virus.

    Frequently Asked Question(FAQ) :

    What is the estimated valuation of Europe regenerative medicine market?
    The market size for regenerative medicine in Europe was surpassed USD 9.5 billion in 2020 and will observe a growth rate of around 18.9% from 2021 to 2027 on account of increasing prevalence of chronic diseases, such as cardiovascular and musculoskeletal.
    Why is regenerative medicine sought for oncology treatment across European market?
    The market share for regenerative medicine in Europe from oncology could expand at around 20.6% CAGR up to 2027 due to rising cases of cancer and the subsequent demand for eliminating disease cells.
    Why has cell therapy strategies gained traction in Europe regenerative medicine industry?
    Cell therapy accounted for more than USD 5.5 billion in Europe industry in 2020 and will observe a similar trend on the back of advancements for the treatment of ischemic heart diseases and ophthalmology disorders.
    What factors will drive the growth of regenerative medicine in France?
    The market for regenerative medicine in France accounted for around 10% share of Europe market in 2020 and will grow with the adoption of innovative therapies for the treatment of chronic diseases.
    Which are the leading companies in Europe regenerative medicine landscape?
    Biosolutions, GlaxoSmithKline, Novartis, Bristol Myers Squibb, Biosolutions and GC pharma are a few of the key players in Europe market.

    Get this research report on Europe Regenerative Medicine Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]